Aura Biosciences, Inc.AURA

$6.34+0.03 (+0.48%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$428M

Small-cap

+17%

2021 — today

10-Year Price

-51%

2021 — today

52-Week Range

$4.97$8.90

Current $6.34· 35%

Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology. Its flagship therapeutic candidate, AU-011, is a VDC currently in development for the treatment of primary choroidal melanoma. Furthermore, Aura Biosciences is investigating AU-011's potential for other ocular oncology applications, such as choroidal metastases.

Valuation in context

P/E ratio

-3.6

N/A

Not meaningful — company is unprofitable

P/B ratio

4.0

Near historic high

Near historic highs — last 10 years

FCF Yield

-21.4%

Historically low

Historically low relative to the last 10 years

Free · No credit card needed

Get alerted when AURA is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.